Detalhe da pesquisa
1.
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proc Natl Acad Sci U S A;
119(21): e2200413119, 2022 05 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35576468
2.
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals.
J Allergy Clin Immunol;
2023 Dec 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38154666
3.
Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019.
Clin Infect Dis;
75(1): e1192-e1194, 2022 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34875033
4.
Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19.
Immunol Cell Biol;
99(9): 917-921, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34309902
5.
Transient autoantibodies to danger signals.
Front Immunol;
14: 1046300, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36742299
6.
Detection of Neutralizing Anti-Type 1 Interferon Autoantibodies.
Curr Protoc;
2(8): e511, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35976040
7.
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2.
Int J Biol Sci;
18(15): 5591-5606, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36263161
8.
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
Res Sq;
2022 Jan 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35043109
9.
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.
Nat Med;
28(5): 1050-1062, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35177862
10.
The Influence of Immune Immaturity on Outcome After Virus Infections.
J Allergy Clin Immunol Pract;
9(2): 641-650, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33551039
11.
SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.
Front Immunol;
12: 720205, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34504497
12.
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
J Exp Med;
218(7)2021 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33890986
13.
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Sci Immunol;
6(62)2021 08 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34413139
14.
An immune-based biomarker signature is associated with mortality in COVID-19 patients.
JCI Insight;
6(1)2021 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33232303
15.
Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients.
RSC Med Chem;
11(3): 358-369, 2020 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33479641
16.
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science;
370(6515)2020 10 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32972996